AbbVie Inc. · Healthcare
$222.47
-6.8%
Jun 17, 2026
D
WeakGraded against ABBV's own history at this drawdown — not the market's.
What it means: ABBV's own history does not strongly favor buying at this level yet.
What to do: Consider watching and waiting for a deeper dip or a higher grade.
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides
Three plain-English paragraphs — current state, historical base rate, and interpretation — so you walk away with context, not a dashboard.
In plain terms: ABBV is 6.8% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.
AbbVie (ABBV) sits 6.8% off its peak and is currently in a shallow pullback, last printing at $222.47. Shallow pullbacks like this are routine — historically US Stocks assets revisit a 5-10% dip several times a year, and most resolve back to highs within weeks.
ABBV reaches this drawdown band repeatedly in its history (705 observations), which is a large sample for the segmentation engine to compute a stable median forward return. The engine uses a rolling 90-day window and gives more weight to recent years — this lets the signal adapt to regime changes (e.g., post-COVID volatility) without losing the long-run base rate.
S&P 500 names behave differently from small-caps at the same drawdown level — the Dipsern segmentation is per-ticker, so historical base rates for ABBV reflect its own volatility regime, not the market's. Shallow pullbacks are where dip-buying frameworks start to pay off, but only marginally. The median forward return in shallow bands is usually positive but not dramatic.
Five tickers closest to ABBV's distance from all-time high. Same category, one tap away.
Dipsern segments the full drawdown range into 20 equal-width bands. The table shows the number of confirmed historical observations in each band for ABBV. Median forward returns, win rates, and prediction errors are available in the full analysis.
We segment 40+ years of ABBV's price history into 20 equal-width drawdown bands and compute forward median returns, win rates, and prediction error per band. No look-ahead bias. Pure NumPy. Open math, gated numbers.
Years of history
40+
Drawdown bands
20
Look-ahead bias
None
Data sources
4
See the Dipsern grade, median returns, win rates, prediction accuracy, 8 interactive charts, historical price paths, and a plain-English verdict for ABBV.
Dipsern is research and a second opinion — not a broker. You'd buy ABBV at your own broker.
Analyze ABBV FreeNo credit card required · 5 free analyses per month
Signal computed Jun 17, 2026 using default parameters (90-day return period, 20 segments, 0.95 decay). Data sourced from Yahoo Finance, Binance, CoinGecko, and Steam Market.